Arthroscopic Meniscus Surgery for Torn Meniscus: The Evidence For and Against by Jeffrey Dach MD

Recently, a 58-year-old post-menopausal woman came to see my in the office. She was doing well on her bioidentical hormone program. However, she was experiencing  bilateral knee pain and swelling. She had been active all her life, hiking, gardening, and chasing after grandchildren, but now had trouble with stairs and long walks. Her MRI scans showed bilateral degenerative medial meniscus tears along with small joint effusions. No advanced osteoarthritis yet, but the changes were clear. Her orthopedic surgeon had recommended arthroscopic partial meniscectomy, called “keyhole” surgery to trim out the torn pieces of the meniscus on both knees. After a full discussion of the medical literature, she decided against arthroscopic knee surgery. Instead, she chose regenerative treatment with stem cell injections into both knees. Six months later she reported excellent pain relief, better function, and no more effusions. She was back to her normal activities and thrilled she had avoided the surgical procedure.

Above Header Image: Posterior medial meniscus anatomy, with its corresponding structures. September 2021. Source Taneja, A.K., Miranda, F.C., Rosemberg, L.A. et al. Meniscal ramp lesions: an illustrated review. Insights Imaging 12, 134 (2021). Author Taneja, A.K., Miranda, F.C., Rosemberg, L.A. et al. This file is licensed under the Creative Commons Attribution 4.0 International license. Link to Image file on wikimedia commons.

A Familiar Story: Arthroscopic Surgery for Knee Osteoarthritis

Twenty years ago, arthroscopic knee surgery was standard treatment for knee osteoarthritis. Surgeons would perform lavage, washing out the joint, or débridement (trimming damaged tissue and smoothing rough cartilage). It was one of the most frequently performed orthopedic procedures in the United States—hundreds of thousands of cases every year.

Then came the landmark 2002 study by Moseley and colleagues. They conducted a randomized, sham-surgery-controlled trial published in the New England Journal of Medicine. Patients with osteoarthritis of the knee were assigned to real arthroscopic surgery (lavage or débridement) or a placebo procedure (skin incisions only, with no actual surgery inside the joint). The results were eye-opening: at no point did the surgery groups report less pain or better function than the placebo group. The improvements seen after “real” surgery were no better than those seen after sham surgery (Moseley et al. 2002). This study, along with a later confirmatory trial in 2008, changed everything. Practice guidelines were updated, Medicare and other payers stopped routine coverage for arthroscopic debridement in osteoarthritis, and the number of these procedures dropped dramatically. Today, arthroscopic “clean-out” surgery for osteoarthritis is rarely performed because the evidence shows it simply doesn’t work. Now, the exact same story is repeating itself with arthroscopic partial meniscectomy for degenerative meniscus tears, the most common knee surgery performed today in middle-aged and older adults.

The Landmark Studies Showing Little or No Benefit for Meniscus Surgery

The strongest evidence comes from the Finnish FIDELITY trial and its long-term follow-ups. In 2013, Sihvonen and colleagues published the original FIDELITY trial.

They randomized 146 patients (average age 52) with degenerative medial meniscus tears to either real arthroscopic partial meniscectomy or sham (placebo) surgery. At two years, there was no difference in pain, function, or symptoms between the groups. Both improved, but the surgery added nothing beyond the placebo effect (Sihvonen et al. 2013). The same team followed these patients out to five years (Sihvonen et al. 2020). Again, no benefit in patient-reported outcomes (WOMET, Lysholm, or knee pain scores). The surgery group actually had a slightly higher risk of radiographic osteoarthritis progression and more mechanical symptoms.

10-year outcomes of the same FIDELITY cohort in the New England Journal of Medicine

The results were crystal clear: no clinical benefit from surgery. In fact, there was a suggestion of worse outcomes, more progression of osteoarthritis (81% vs. 70%) and more knee replacements or osteotomies in the meniscectomy group (Kalske et al. 2026).

These findings line up with other major trials. The MeTeOR trial by Katz and colleagues (2013) compared surgery plus physical therapy versus physical therapy alone in patients with meniscus tears and osteoarthritis. No significant difference in outcomes at one year (Katz et al. 2013).

A 2015 systematic review and meta-analysis by Thorlund and colleagues pulled together all the best randomized trials and reached the same conclusion: arthroscopic surgery for degenerative knee problems (including meniscus tears) offers little or no benefit over conservative care and may even cause harm (Thorlund et al. 2015).

Taken together, these studies have changed practice guidelines worldwide. For the typical middle-aged patient with a degenerative tear and no advanced arthritis, the evidence says surgery is not the first choice.

Studies That Appear to Show Benefit

On the other hand, earlier, less rigorously controlled studies reported better results with surgery. These are the papers often cited by surgeons who still recommend the procedure.

Yim and colleagues (2013) compared arthroscopic partial meniscectomy with nonoperative treatment for degenerative tears of the medial meniscus. They found significantly better short-term pain relief and function in the surgery group (Yim et al. 2013).

Chatain and colleagues (2003) followed patients for at least 10 years after medial or lateral partial meniscectomy on stable knees. They reported good-to-excellent long-term functional outcomes and relatively low re-operation rates, suggesting durable benefit in carefully selected patients (Chatain et al. 2003).

Gauffin and colleagues (2014) conducted a single-blinded randomized trial of middle-aged patients with meniscal symptoms. They found a modest but statistically significant improvement in pain and function at one year favoring surgery plus exercise over exercise alone (Gauffin et al. 2014).

These studies have been used for years to support surgery. So why the conflicting results?

Why the Discrepancy? Understanding the Evidence

The apparent contradiction is not mysterious once you look closely.

Four key factors explain almost everything:

Type of Tear and Patient

Degenerative tears (the majority in middle age) are often part of normal aging and wear-and-tear arthritis. The pain may not even come primarily from the meniscus. Traumatic tears in younger patients, or true “bucket-handle” tears causing mechanical locking, behave differently and may respond better to intervention. The “no-benefit” trials focused on degenerative cases; the “benefit” studies often included more favorable tear patterns or younger patients.

Study Design and Placebo Effect

The modern sham-controlled, blinded trials (FIDELITY, Moseley for OA, etc.) eliminate the powerful placebo response that comes from having surgery. Older studies were open-label or had weaker comparators, so the surgery group looked better simply because patients expected to improve.

Timing of Results

Some studies show a small short-term advantage (3–12 months) for surgery in relieving mechanical symptoms. By two years and beyond, however, the non-surgical groups catch up, and any early edge disappears—or even reverses with more osteoarthritis progression after meniscectomy.

Subgroups and Real-World Selection

Even in the negative trials, a small subset of patients with clear mechanical locking from an unstable fragment may still benefit from prompt surgery. But when you average everyone together (the proper scientific approach), the overall benefit vanishes.

In other words, the high-quality evidence has refined our understanding: surgery is not a one-size-fits-all solution. It may still have a limited role in carefully selected younger patients with acute traumatic tears and true locking, but routine arthroscopy for degenerative tears in middle-aged adults is hard to justify.

If your doctor recommends meniscus surgery, ask two simple questions:

• Is this a degenerative tear or a traumatic one?
• Have we given high-quality physical therapy and time a fair chance?

Most patients with degenerative meniscal tears do just as well, or better, with conservative or regenerative options such as stem cell injections, physical therapy, weight management, and anti-inflammatory strategies. Avoiding unnecessary arthroscopic surgery spares you the small but real risks of accelerated arthritis and future knee replacement.

The evidence has been consistent now for over a decade. Just as we saw with arthroscopic surgery for osteoarthritis, the era of routine “clean-out” knee arthroscopies for degenerative meniscus tears is coming to an end, and that’s good news. However, for the patients with clear cut mechanical interference with joint functions such as a “Bucket Handle” tear, arthroscopic repair remains a good procedure that can restore function. This is also true for most young atheletes who suffer traumatic injuries to the knee meniscus.

Articles with related interest: The Power of the Placebo Effect

Jeffrey Dach MD
7450 Griffin Road, Suite 190
Davie, Fl 33314
954-792-4663
my blog: www.jeffreydachmd.com 
Bioidentical Hormones 101 Second Edition
Menopausal Hormone Replacement, Health Benefits
Natural Thyroid Toolkit by Jeffrey Dach MD
Cracking Cancer Toolkit ebook

References :

Chatain, Frédéric, et al. “A Comparative Study of Medial Versus Lateral Arthroscopic Partial Meniscectomy on Stable Knees: 10-Year Minimum Follow-Up.” Arthroscopy: The Journal of Arthroscopic & Related Surgery, vol. 19, no. 8, Oct. 2003, pp. 842–49, https://www.arthroscopyjournal.org/article/S0749-8063(03)00734-7/fulltext.

jdach1.typepad.com/blog/
disc.yourwebapps.com/Indices/244066.html
disc.yourwebapps.com/Indices/244067.html
http://sci.med.narkive.com/covV2Qo2/jeffrey-dach-book-announcment-natural-medicine-101

Disclaimer

All characters or patient names appearing on this web site or copied elsewhere are purely fictitious. Any resemblance to real persons, living or dead, is purely coincidental.

The reader is advised to discuss the comments on these pages with his/her personal physicians and to only act upon the advice of his/her personal physician. Also note that concerning an answer which appears as an electronically posted question, I am NOT creating a physician — patient relationship. Although identities will remain confidential as much as possible, as I can not control the media, I can not take responsibility for any breaches of confidentiality that may occur.

Link to this Article

Copyright © 2026 Jeffrey Dach MD All Rights Reserved. This article may be reproduced on the internet without permission, provided there is a link to this page and proper credit is given. See Repost Guidelines.

FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

Serving Areas of: Hollywood, Aventura, Miami, Fort Lauderdale, Pembroke Pines, Miramar, Davie, Coral Springs, Cooper City, Sunshine Ranches, Hallandale, Surfside, Miami Beach, Sunny Isles, Normandy Isles, Coral Gables, Hialeah, Golden Beach ,Kendall,sunrise, coral springs, parkland,pompano, boca raton, palm beach, weston, dania beach, tamarac, oakland park, boynton beach, delray,lake worth,wellington,plantation

Published on May 18th, 2026 by Jeffrey Dach MD